Extraxa Pharma Private Limited

Extraxa Pharma Private Limited - healthcare in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U74120MH2012PTC229677 Incorporated 14 April 2012 ROC Mumbai HQ Mumbai, Maharashtra, India
Struck Off Private Limited Company healthcare
Data last updated
Revenue · FY 2023
₹955
▼ 100.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
14 yrs
Est. 2012
Last financials
Mar 2023
Balance sheet date

About Extraxa Pharma Private Limited

Data last updated:

Extraxa Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Inventys Research Company Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in ayurvedic products and services, a part of the broader healthcare sector. Incorporated on 14 April 2012.

Registered with ROC Mumbai under CIN U74120MH2012PTC229677.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Deepak Baburao Birewar and Neeta Ajit Naik.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: D – 514 Kanakia Zillion Bkc Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070.

As per the financials filed for FY 2023, the company reported a revenue of ₹955, a decline of 100% compared to the previous year.

It operated as a subsidiary of Inventys Research Company Private Limited.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk. The last known website on record is inventys.in.

Company Details of Extraxa Pharma Private Limited
CIN U74120MH2012PTC229677
Registration Number 229677
Incorporation Date 14 April 2012
ROC Mumbai
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Parent Company Inventys Research Company Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    D – 514 Kanakia Zillion Bkc Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070
  • Industry
    Healthcare, Ayurvedic Products & Services
Company report
Extraxa Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Extraxa Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Extraxa Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Extraxa Pharma

Extraxa Pharma Private Limited is audited by VINAY BHUSHAN & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
VINAY BHUSHAN & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history for Extraxa Pharma Private Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Extraxa Pharma Private Limited

Extraxa Pharma has 3 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Deepak Baburao BirewarDirector14 Apr 201214 Years 5 MonthsAs last reported
Neeta Ajit NaikDirector14 Apr 201214 Years 5 MonthsAs last reported
Shobana BirewarDirector14 Apr 201214 Years 5 MonthsAs last reported

Financials of Extraxa Pharma Private Limited FY 2023 filings available

Extraxa Pharma Private Limited reported revenue of ₹955 (down 100.00% YoY) for FY 2023.

Revenue · FY 2023
₹955 ▼ 100.00%
Premium access

Ten-year financial statements for Extraxa Pharma Private Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Extraxa Pharma

Premium access

Shareholding and ownership data for Extraxa Pharma Private Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Extraxa Pharma

Extraxa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Extraxa Pharma

Employment history and EPFO contributions of people linked to Extraxa Pharma.

Premium access

Employee and EPFO history for Extraxa Pharma Private Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Extraxa Pharma

Premium access

GST registrations and filing compliance for Extraxa Pharma Private Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Extraxa Pharma

Premium access

Credit ratings, litigation, and regulatory alerts for Extraxa Pharma Private Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Extraxa Pharma

Premium access

MSME payment history for Extraxa Pharma Private Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Extraxa Pharma

Premium access

Corporate group structure for Extraxa Pharma Private Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Extraxa Pharma

Premium access

MCA filings and documents for Extraxa Pharma Private Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Extraxa Pharma

Activity
30 Sep 2023
Extraxa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Extraxa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Directors
14 Apr 2012
Deepak Baburao Birewar was appointed as a Director on 14 Apr 2012 & has been associated with this company since 14 years 5 months.
Directors
14 Apr 2012
Neeta Ajit Naik was appointed as a Director on 14 Apr 2012 & has been associated with this company since 14 years 5 months.
Directors
14 Apr 2012
Shobana Birewar was appointed as a Director on 14 Apr 2012 & has been associated with this company since 14 years 5 months.
Activity
14 Apr 2012
Extraxa Pharma Private Limited was registered on 14 Apr 2012 with Roc Mumbai & aged 14 years 5 months as per MCA records.

Frequently Asked Questions about Extraxa Pharma Private Limited

Extraxa Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Extraxa Pharma is a struck-off private limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 14 April 2012 and is registered under CIN U74120MH2012PTC229677. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Extraxa Pharma are:

The CIN (Corporate Identification Number) of Extraxa Pharma is U74120MH2012PTC229677. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Extraxa Pharma is healthcare. The company specifically operates in ayurvedic products and services. The company was active in this sector before being struck off.

The company has its registered office at D – 514 Kanakia Zillion Bkc Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available